Embed this press release by copying the code below:
CEL-SCI Reaches Full Enrollment in Pivotal Phase 3 Head and Neck Cancer Study
CEL-SCI Reaches Full Enrollment in Pivotal Phase 3 Head and Neck Cancer Study